Tel Aviv, Israel - January 4, 2017 – BioLineRx (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that its Chief Executive Officer, Philip Serlin, will be presenting at the Biotech Showcase 2017 Conference being held in San Francisco, CA.
The BioLineRx presentation is scheduled to start at 2:30 pm PST on Tuesday, January 10, 2017. A live audio webcast of the presentation will be available online at BioLineRx's investor web page
. An archive of the event will also be available for those unable to listen live. Company management will be available to participate in one-on-one meetings with investors who are registered to attend the conference. Meetings may also be scheduled outside of Biotech Showcase by contacting BioLineRx’s investor relations